Published 2017 | Version v1
Publication Metadata-only

Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets.

De Stefano, N
Giorgio, A
Battaglini, M
De Leucio, A
Hicking, C
Dangond, F
Giovannoni, G
SORMANI, MARIA PIA
Others:
De Stefano, N
Giorgio, A
Battaglini, M
De Leucio, A
Hicking, C
Dangond, F
Giovannoni, G
Sormani, MARIA PIA

Additional details

Identifiers Origin repository
Created:
May 13, 2023
Modified:
December 1, 2023